Intensified anti-TNF treatment downregulates the phenotype in ulcerative colitis: a 13-year prospective follow-up study
BackgroundModerate to severe ulcerative colitis (UC) is generally treated with a step-up algorithm from 5-aminosalicylic acid (5-ASA) to biological agents. There is no general recommendation if or when to de-escalate or discontinue biological therapy. In this study, we performed biological therapy w...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2024-01-01
|
| Серія: | Frontiers in Gastroenterology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fgstr.2023.1304944/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|